Metformin (Malay Wikipedia)

Analysis of information sources in references of the Wikipedia article "Metformin" in Malay language version.

refsWebsite

Global rank Malay rank

88nih.gov

4^th place

14^th place

59doi.org

2^nd place

8^th place

17web.archive.org

1^st place

15wikipedia.org

low place

3harvard.edu

18^th place

46^th place

2drugs.com

399^th place

730^th place

2books.google.com

3^rd place

10^th place

2clincalc.com

3,912^th place

low place

2nice.org.uk

3,258^th place

3,117^th place

1semanticscholar.org

11^th place

67^th place

1tga.gov.au

3,984^th place

5,878^th place

1canada.ca

1,712^th place

4,938^th place

1medicines.org.uk

3,823^rd place

5,861^st place

1chemsrc.com

low place

5,185^th place

1handle.net

102^nd place

419^th place

1archive.org

6^th place

27^th place

1webcitation.org

24^th place

57^th place

1rcog.org.uk

low place

9,464^th place

1nhs.uk

1,989^th place

1,427^th place

1aspca.org

low place

5,829^th place

1zenodo.org

621^st place

1,190^th place

1mcgill.ca

2,527^th place

1,855^th place

archive.org

Maharani U (2009). "Chapter 27: Diabetes Mellitus & Hypoglycemia". Dalam Papadakis MA, McPhee SJ (penyunting). Current Medical Diagnosis and Treatment 2010 (ed. 49th). McGraw-Hill Medical. m/s. 1092–93. ISBN 978-0-07-162444-2.

aspca.org

"Metformin overdose in dogs and cats" (PDF). Veterinary Medicine (April): 231–33. 2007. Diarkibkan daripada yang asal (PDF) pada 23 Oktober 2007.

books.google.com

Fischer J (2010). Analogue-based Drug Discovery II. John Wiley & Sons. m/s. 49. ISBN 978-3-527-63212-1. Diarkibkan daripada yang asal pada 8 September 2017.
Stargrove MB, Treasure J, McKee DL (2008). Herb, nutrient, and drug interactions : clinical implications and therapeutic strategies. St. Louis, Mo.: Mosby/Elsevier. m/s. 217. ISBN 978-0-323-02964-3. Diarkibkan daripada yang asal pada 8 September 2017.

canada.ca

health-products.canada.ca

"Metformin Hydrochloride". Health Canada. Diarkibkan daripada yang asal pada 6 Mac 2023. Dicapai pada 6 Mac 2023.

chemsrc.com

"Metformin". www.chemsrc.com. Diarkibkan daripada yang asal pada 12 Jun 2017. Dicapai pada 10 Mei 2018.

clincalc.com

"The Top 300 of 2020". ClinCalc. Diarkibkan daripada yang asal pada 18 Mac 2020. Dicapai pada 7 Oktober 2022.
"Metformin - Drug Usage Statistics". ClinCalc. Diarkibkan daripada yang asal pada 7 Oktober 2021. Dicapai pada 7 Oktober 2022.

doi.org

Sirtori CR, Franceschini G, Galli-Kienle M, Cighetti G, Galli G, Bondioli A, Conti F (Disember 1978). "Disposition of metformin (N,N-dimethylbiguanide) in man". Clinical Pharmacology and Therapeutics. 24 (6): 683–93. doi:10.1002/cpt1978246683. PMID 710026. S2CID 24531910.
Dunn CJ, Peters DH (Mei 1995). "Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus". Drugs. 49 (5): 721–49. doi:10.2165/00003495-199549050-00007. PMID 7601013.
Hundal RS, Inzucchi SE (2003). "Metformin: new understandings, new uses". Drugs. 63 (18): 1879–94. doi:10.2165/00003495-200363180-00001. PMID 12930161.
"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022". Diabetes Care. 45 (Suppl 1): S125–S143. Januari 2022. doi:10.2337/dc22-s009. PMID 34964831 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD". European Heart Journal. 41 (2): 255–323. Januari 2020. doi:10.1093/eurheartj/ehz486. PMID 31497854. Unknown parameter |displayauthors= ignored (bantuan)
"Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis". Annals of Internal Medicine. 164 (11): 740–751. June 2016. doi:10.7326/M15-2650. PMID 27088241. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin in prevention and treatment of antipsychotic-induced weight gain: a systematic review and meta-analysis". BMC Psychiatry. 16 (1): 341. October 2016. doi:10.1186/s12888-016-1049-5. PMC 5048618. PMID 27716110.
"Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium". Acta Physiologica. 219 (1): 138–151. Januari 2017. doi:10.1111/apha.12644. PMID 26680745.
"Do Patients Die with or from Metformin-Associated Lactic Acidosis (MALA)? Systematic Review and Meta-analysis of pH and Lactate as Predictors of Mortality in MALA". Journal of Medical Toxicology. 16 (2): 222–229. April 2020. doi:10.1007/s13181-019-00755-6. PMC 7099117. PMID 31907741.
"Use of metformin in the setting of mild-to-moderate renal insufficiency". Diabetes Care. 34 (6): 1431–7. June 2011. doi:10.2337/dc10-2361. PMC 3114336. PMID 21617112.
"GDF15 mediates the effects of metformin on body weight and energy balance". Nature. 578 (7795): 444–448. Februari 2020. doi:10.1038/s41586-019-1911-y. PMC 7234839. PMID 31875646. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss". Nature Metabolism. 1 (12): 1202–1208. December 2019. doi:10.1038/s42255-019-0146-4. PMID 32694673. Unknown parameter |displayauthors= ignored (bantuan)
"Medical Management of Diabesity: Do We Have Realistic Targets?". Current Diabetes Reports. 17 (1): 4. Januari 2017. doi:10.1007/s11892-017-0828-9. PMID 28101792.
"Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis". Proceedings of the National Academy of Sciences of the United States of America. 119 (10): e2122287119. March 2022. Bibcode:2022PNAS..11922287L. doi:10.1073/pnas.2122287119. PMC 8916010 Check |pmc= value (bantuan). PMID 35238637 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Metformin in polycystic ovary syndrome: systematic review and meta-analysis". BMJ. 327 (7421): 951–3. October 2003. doi:10.1136/bmj.327.7421.951. PMC 259161. PMID 14576245.
"Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations". Annals of Internal Medicine. 154 (9): 602–13. May 2011. doi:10.7326/0003-4819-154-9-201105030-00336. PMC 3733115. PMID 21403054. Unknown parameter |displayauthors= ignored (bantuan)
"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)". Diabetes Care. 35 (6): 1364–79. June 2012. doi:10.2337/dc12-0413. PMC 3357214. PMID 22517736. Unknown parameter |displayauthors= ignored (bantuan)
"Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians". Annals of Internal Medicine. 156 (3): 218–31. Februari 2012. doi:10.7326/0003-4819-156-3-201202070-00011. PMID 22312141.
"Is metformin still the most efficacious first-line oral hypoglycaemic drug in treating type 2 diabetes? A network meta-analysis of randomized controlled trials". Obesity Reviews. 20 (1): 1–12. Januari 2019. doi:10.1111/obr.12753. PMID 30230172.
"ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary". Diabetes & Vascular Disease Research. 11 (3): 133–73. May 2014. doi:10.1177/1479164114525548. PMID 24800783. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin monotherapy for adults with type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews. 2020 (6): CD012906. June 2020. doi:10.1002/14651858.CD012906.pub2. PMC 7386876. PMID 32501595.
"Efficacy of metformin in the treatment of NIDDM. Meta-analysis". Diabetes Care. 22 (1): 33–7. Januari 1999. doi:10.2337/diacare.22.1.33. PMID 10333900.
"Metformin and body weight". International Journal of Obesity. 32 (1): 61–72. Januari 2008. doi:10.1038/sj.ijo.0803695. PMID 17653063.
"Drug interventions for the treatment of obesity in children and adolescents". The Cochrane Database of Systematic Reviews. 11 (11): CD012436. November 2016. doi:10.1002/14651858.CD012436. PMC 6472619. PMID 27899001. Unknown parameter |displayauthors= ignored (bantuan)
"Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus". Annals of Internal Medicine. 147 (6): 386–99. September 2007. doi:10.7326/0003-4819-147-6-200709180-00178. PMID 17638715. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews. 2019 (12): CD008558. December 2019. doi:10.1002/14651858.CD008558.pub2. PMC 6889926. PMID 31794067.
"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility". The Cochrane Database of Systematic Reviews. 11 (2): CD003053. November 2017. doi:10.1002/14651858.CD003053.pub6. PMC 6486196. PMID 29183107. Our updated review suggests that metformin alone Mei be beneficial over placebo for live birth, although the evidence quality was low.
"Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview". Acta Obstetricia et Gynecologica Scandinavica. 91 (6): 658–78. June 2012. doi:10.1111/j.1600-0412.2012.01385.x. PMID 22375613.
"Effects of metformin use in pregnant patients with polycystic ovary syndrome". Journal of Human Reproductive Sciences. 5 (2): 166–9. May 2012. doi:10.4103/0974-1208.101012. PMC 3493830. PMID 23162354.
"Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews". Clinical Endocrinology. 89 (5): 535–553. November 2018. doi:10.1111/cen.13753. PMID 29846959. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome". The Cochrane Database of Systematic Reviews. 2020 (12): CD006105. December 2020. doi:10.1002/14651858.CD006105.pub4. PMC 8171384. PMID 33347618.
"Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes". The Cochrane Database of Systematic Reviews. 2018 (7): CD010564. July 2018. doi:10.1002/14651858.CD010564.pub2. PMC 6513233. PMID 30039871.
The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (March 2008). "Consensus on infertility treatment related to polycystic ovary syndrome". Human Reproduction. 23 (3): 462–77. doi:10.1093/humrep/dem426. PMID 18308833.
"Metformin in polycystic ovary syndrome". Annals of the New York Academy of Sciences. 1205 (1): 192–8. September 2010. Bibcode:2010NYASA1205..192D. doi:10.1111/j.1749-6632.2010.05679.x. PMID 20840272.
"Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome". European Journal of Endocrinology. 162 (2): 193–212. Februari 2010. doi:10.1530/EJE-09-0733. PMID 19841045.
"Metformin: safety in cardiac patients". Heart. 96 (2): 99–102. Januari 2010. doi:10.1136/hrt.2009.173773. PMID 19564648.
"Metformin in chronic kidney disease: time for a rethink". Peritoneal Dialysis International. 34 (4): 353–7. June 2014. doi:10.3747/pdi.2013.00344. PMC 4079480. PMID 24711640.
"Molecular mechanism of action of metformin: old or new insights?". Diabetologia. 56 (9): 1898–906. September 2013. doi:10.1007/s00125-013-2991-0. PMC 3737434. PMID 23835523.
"The antidiabetic gutsy role of metformin uncovered?". Gut. 63 (5): 706–7. May 2014. doi:10.1136/gutjnl-2013-305370. PMID 23840042.
"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase". Nature. 510 (7506): 542–6. June 2014. Bibcode:2014Natur.510..542M. doi:10.1038/nature13270. PMC 4074244. PMID 24847880. Unknown parameter |displayauthors= ignored (bantuan)
Tilley J, Grimsby J, Erickson S, Berthel S (2010). "Diabetes Drugs: Present and Emerging". Burger's Medicinal Chemistry and Drug Discovery. m/s. 1–38. doi:10.1002/0471266949.bmc198. ISBN 978-0471266945.
"The preparation of methylguanidine, and of ββ-dimethylguanidine by the interaction of dicyandiamide, and methylammonium and dimethylammonium chlorides respectively". J. Chem. Soc., Trans. 121: 1790–95. 1922. doi:10.1039/CT9222101790. Diarkibkan daripada yang asal pada 8 Jun 2021. Dicapai pada 4 September 2020.
"Hypoglycemic Agents. I Chemical Properties of β-Phenethylbiguanide. A New Hypoglycemic Agent". J Am Chem Soc. 81 (9): 2220–25. 1959. doi:10.1021/ja01518a052.
"The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials". Pharmacological Research. 159: 104799. September 2020. doi:10.1016/j.phrs.2020.104799. PMID 32278041. Unknown parameter |displayauthors= ignored (bantuan)
"Diabetes drugs for nonalcoholic fatty liver disease: a systematic review". Systematic Reviews. 8 (1): 295. November 2019. doi:10.1186/s13643-019-1200-8. PMC 6884753. PMID 31783920.
"Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis". World Journal of Gastroenterology. 24 (30): 3361–3373. August 2018. doi:10.3748/wjg.v24.i30.3361. PMC 6092580. PMID 30122876.
"Metformin treatment to prevent early puberty in girls with precocious pubarche". The Journal of Clinical Endocrinology and Metabolism. 91 (8): 2888–91. August 2006. doi:10.1210/jc.2006-0336. PMID 16684823.
"Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence". The Journal of Clinical Endocrinology and Metabolism. 96 (8): E1262-7. August 2011. doi:10.1210/jc.2011-0555. PMID 21632811.
"Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism". Reviews in Endocrine & Metabolic Disorders. 10 (1): 63–76. March 2009. doi:10.1007/s11154-008-9096-y. PMID 18726694.
"Effect of metformin on prostate cancer outcomes after radical prostatectomy". Urologic Oncology. 32 (1): 43.e1–7. Januari 2014. doi:10.1016/j.urolonc.2013.05.005. PMC 4006350. PMID 23810664. Metformin use at time of RP was extracted from the Mayo Clinic electronic medical record (EMR) by searching in the 3 months prior to the RP for the terms- metformin, Glucophage, Glumetza, Riomet, Fortamet, Obimet, Gluformin, Dianben, Diabex, Diaformin or Metsol.
"Metformin in cancer therapy: a new perspective for an old antidiabetic drug?". Molecular Cancer Therapeutics. 9 (5): 1092–9. May 2010. doi:10.1158/1535-7163.MCT-09-1186. PMID 20442309.
"Risk of cancer in diabetes: the effect of metformin". ISRN Endocrinology. 2013: 636927. September 2013. doi:10.1155/2013/636927. PMC 3800579. PMID 24224094.
"Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis". Ageing Research Reviews. 40: 31–44. November 2017. doi:10.1016/j.arr.2017.08.003. PMID 28802803.
"Metformin as Anti-Aging Therapy: Is It for Everyone?". Trends in Endocrinology and Metabolism. 30 (10): 745–755. October 2019. doi:10.1016/j.tem.2019.07.015. PMC 6779524. PMID 31405774.
"Metformin: A Hopeful Promise in Aging Research". Cold Spring Harbor Perspectives in Medicine. 6 (3): a025932. March 2016. doi:10.1101/cshperspect.a025932. PMC 4772077. PMID 26931809.
"Metformin for Treatment of Fragile X Syndrome and Other Neurological Disorders". Annual Review of Medicine. 70: 167–181. Januari 2019. doi:10.1146/annurev-med-081117-041238. PMID 30365357. Diarkibkan daripada yang asal pada 6 Mac 2023. Dicapai pada 9 Oktober 2022.
"Repurposing metformin: an old drug with new tricks in its binding pockets". The Biochemical Journal. 471 (3): 307–22. November 2015. doi:10.1042/bj20150497. PMC 4613459. PMID 26475449.
"Metformin as a Tool to Target Aging". Cell Metabolism. 23 (6): 1060–1065. June 2016. doi:10.1016/j.cmet.2016.05.011. PMC 5943638. PMID 27304507.
"A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan". Frontiers in Endocrinology. 12: 718942. 2021. doi:10.3389/fendo.2021.718942. PMC 8374068 Check |pmc= value (bantuan). PMID 34421827 Check |pmid= value (bantuan).

drugs.com

"Metformin Use During Pregnancy". Drugs.com. 10 September 2019. Diarkibkan daripada yang asal pada 16 April 2020. Dicapai pada 4 Februari 2020.
"Metformin Hydrochloride". The American Society of Health-System Pharmacists. Diarkibkan daripada yang asal pada 24 Disember 2016. Dicapai pada 2 Januari 2017.

handle.net

hdl.handle.net

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

harvard.edu

ui.adsabs.harvard.edu

"Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis". Proceedings of the National Academy of Sciences of the United States of America. 119 (10): e2122287119. March 2022. Bibcode:2022PNAS..11922287L. doi:10.1073/pnas.2122287119. PMC 8916010 Check |pmc= value (bantuan). PMID 35238637 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Metformin in polycystic ovary syndrome". Annals of the New York Academy of Sciences. 1205 (1): 192–8. September 2010. Bibcode:2010NYASA1205..192D. doi:10.1111/j.1749-6632.2010.05679.x. PMID 20840272.
"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase". Nature. 510 (7506): 542–6. June 2014. Bibcode:2014Natur.510..542M. doi:10.1038/nature13270. PMC 4074244. PMID 24847880. Unknown parameter |displayauthors= ignored (bantuan)

mcgill.ca

escholarship.mcgill.ca

"Metformin for Treatment of Fragile X Syndrome and Other Neurological Disorders". Annual Review of Medicine. 70: 167–181. Januari 2019. doi:10.1146/annurev-med-081117-041238. PMID 30365357. Diarkibkan daripada yang asal pada 6 Mac 2023. Dicapai pada 9 Oktober 2022.

medicines.org.uk

"Glucophage 500 mg film coated tablets - Summary of Product Characteristics (SmPC)". (emc). 25 Oktober 2022. Diarkibkan daripada yang asal pada 20 Jun 2022. Dicapai pada 5 Mac 2023.

nhs.uk

"Metformin: medicine to treat type 2 diabetes". National Health Service. 25 Februari 2019. Diarkibkan daripada yang asal pada 11 Mac 2021. Dicapai pada 15 Oktober 2020.

nice.org.uk

National Collaborating Centre for Women's and Children's Health (2004). Fertility: assessment and treatment for people with fertility problems (PDF). London: Royal College of Obstetricians and Gynaecologists. m/s. 58–59. ISBN 978-1-900364-97-3. Diarkibkan daripada yang asal (PDF) pada 11 Julai 2009.

bnf.nice.org.uk

"METFORMIN HYDROCHLORIDE". NICE. Diarkibkan daripada yang asal pada 10 Jun 2021. Dicapai pada 15 Oktober 2020.

nih.gov

pubmed.ncbi.nlm.nih.gov

Sirtori CR, Franceschini G, Galli-Kienle M, Cighetti G, Galli G, Bondioli A, Conti F (Disember 1978). "Disposition of metformin (N,N-dimethylbiguanide) in man". Clinical Pharmacology and Therapeutics. 24 (6): 683–93. doi:10.1002/cpt1978246683. PMID 710026. S2CID 24531910.
Lucis OJ (Januari 1983). "The status of metformin in Canada". Canadian Medical Association Journal. 128 (1): 24–6. PMC 1874707. PMID 6847752.
Dunn CJ, Peters DH (Mei 1995). "Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus". Drugs. 49 (5): 721–49. doi:10.2165/00003495-199549050-00007. PMID 7601013.
Hundal RS, Inzucchi SE (2003). "Metformin: new understandings, new uses". Drugs. 63 (18): 1879–94. doi:10.2165/00003495-200363180-00001. PMID 12930161.
"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022". Diabetes Care. 45 (Suppl 1): S125–S143. Januari 2022. doi:10.2337/dc22-s009. PMID 34964831 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD". European Heart Journal. 41 (2): 255–323. Januari 2020. doi:10.1093/eurheartj/ehz486. PMID 31497854. Unknown parameter |displayauthors= ignored (bantuan)
"Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis". Annals of Internal Medicine. 164 (11): 740–751. June 2016. doi:10.7326/M15-2650. PMID 27088241. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin in prevention and treatment of antipsychotic-induced weight gain: a systematic review and meta-analysis". BMC Psychiatry. 16 (1): 341. October 2016. doi:10.1186/s12888-016-1049-5. PMC 5048618. PMID 27716110.
"Type 2 diabetes and metformin. First choice for monotherapy: weak evidence of efficacy but well-known and acceptable adverse effects". Prescrire International. 23 (154): 269–272. November 2014. PMID 25954799.
"Metformin is not just an antihyperglycaemic drug but also has protective effects on the vascular endothelium". Acta Physiologica. 219 (1): 138–151. Januari 2017. doi:10.1111/apha.12644. PMID 26680745.
"Do Patients Die with or from Metformin-Associated Lactic Acidosis (MALA)? Systematic Review and Meta-analysis of pH and Lactate as Predictors of Mortality in MALA". Journal of Medical Toxicology. 16 (2): 222–229. April 2020. doi:10.1007/s13181-019-00755-6. PMC 7099117. PMID 31907741.
"Use of metformin in the setting of mild-to-moderate renal insufficiency". Diabetes Care. 34 (6): 1431–7. June 2011. doi:10.2337/dc10-2361. PMC 3114336. PMID 21617112.
"GDF15 mediates the effects of metformin on body weight and energy balance". Nature. 578 (7795): 444–448. Februari 2020. doi:10.1038/s41586-019-1911-y. PMC 7234839. PMID 31875646. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss". Nature Metabolism. 1 (12): 1202–1208. December 2019. doi:10.1038/s42255-019-0146-4. PMID 32694673. Unknown parameter |displayauthors= ignored (bantuan)
"Medical Management of Diabesity: Do We Have Realistic Targets?". Current Diabetes Reports. 17 (1): 4. Januari 2017. doi:10.1007/s11892-017-0828-9. PMID 28101792.
"Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis". Proceedings of the National Academy of Sciences of the United States of America. 119 (10): e2122287119. March 2022. Bibcode:2022PNAS..11922287L. doi:10.1073/pnas.2122287119. PMC 8916010 Check |pmc= value (bantuan). PMID 35238637 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Metformin in polycystic ovary syndrome: systematic review and meta-analysis". BMJ. 327 (7421): 951–3. October 2003. doi:10.1136/bmj.327.7421.951. PMC 259161. PMID 14576245.
"Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations". Annals of Internal Medicine. 154 (9): 602–13. May 2011. doi:10.7326/0003-4819-154-9-201105030-00336. PMC 3733115. PMID 21403054. Unknown parameter |displayauthors= ignored (bantuan)
"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)". Diabetes Care. 35 (6): 1364–79. June 2012. doi:10.2337/dc12-0413. PMC 3357214. PMID 22517736. Unknown parameter |displayauthors= ignored (bantuan)
"Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians". Annals of Internal Medicine. 156 (3): 218–31. Februari 2012. doi:10.7326/0003-4819-156-3-201202070-00011. PMID 22312141.
"Is metformin still the most efficacious first-line oral hypoglycaemic drug in treating type 2 diabetes? A network meta-analysis of randomized controlled trials". Obesity Reviews. 20 (1): 1–12. Januari 2019. doi:10.1111/obr.12753. PMID 30230172.
"ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary". Diabetes & Vascular Disease Research. 11 (3): 133–73. May 2014. doi:10.1177/1479164114525548. PMID 24800783. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin monotherapy for adults with type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews. 2020 (6): CD012906. June 2020. doi:10.1002/14651858.CD012906.pub2. PMC 7386876. PMID 32501595.
"Efficacy of metformin in the treatment of NIDDM. Meta-analysis". Diabetes Care. 22 (1): 33–7. Januari 1999. doi:10.2337/diacare.22.1.33. PMID 10333900.
"Metformin and body weight". International Journal of Obesity. 32 (1): 61–72. Januari 2008. doi:10.1038/sj.ijo.0803695. PMID 17653063.
"Drug interventions for the treatment of obesity in children and adolescents". The Cochrane Database of Systematic Reviews. 11 (11): CD012436. November 2016. doi:10.1002/14651858.CD012436. PMC 6472619. PMID 27899001. Unknown parameter |displayauthors= ignored (bantuan)
"Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus". Annals of Internal Medicine. 147 (6): 386–99. September 2007. doi:10.7326/0003-4819-147-6-200709180-00178. PMID 17638715. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews. 2019 (12): CD008558. December 2019. doi:10.1002/14651858.CD008558.pub2. PMC 6889926. PMID 31794067.
"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility". The Cochrane Database of Systematic Reviews. 11 (2): CD003053. November 2017. doi:10.1002/14651858.CD003053.pub6. PMC 6486196. PMID 29183107. Our updated review suggests that metformin alone Mei be beneficial over placebo for live birth, although the evidence quality was low.
"Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview". Acta Obstetricia et Gynecologica Scandinavica. 91 (6): 658–78. June 2012. doi:10.1111/j.1600-0412.2012.01385.x. PMID 22375613.
"Effects of metformin use in pregnant patients with polycystic ovary syndrome". Journal of Human Reproductive Sciences. 5 (2): 166–9. May 2012. doi:10.4103/0974-1208.101012. PMC 3493830. PMID 23162354.
"Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews". Clinical Endocrinology. 89 (5): 535–553. November 2018. doi:10.1111/cen.13753. PMID 29846959. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome". The Cochrane Database of Systematic Reviews. 2020 (12): CD006105. December 2020. doi:10.1002/14651858.CD006105.pub4. PMC 8171384. PMID 33347618.
"Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes". The Cochrane Database of Systematic Reviews. 2018 (7): CD010564. July 2018. doi:10.1002/14651858.CD010564.pub2. PMC 6513233. PMID 30039871.
The Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (March 2008). "Consensus on infertility treatment related to polycystic ovary syndrome". Human Reproduction. 23 (3): 462–77. doi:10.1093/humrep/dem426. PMID 18308833.
"Metformin in polycystic ovary syndrome". Annals of the New York Academy of Sciences. 1205 (1): 192–8. September 2010. Bibcode:2010NYASA1205..192D. doi:10.1111/j.1749-6632.2010.05679.x. PMID 20840272.
"Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome". European Journal of Endocrinology. 162 (2): 193–212. Februari 2010. doi:10.1530/EJE-09-0733. PMID 19841045.
"Metformin: safety in cardiac patients". Heart. 96 (2): 99–102. Januari 2010. doi:10.1136/hrt.2009.173773. PMID 19564648.
"Metformin in chronic kidney disease: time for a rethink". Peritoneal Dialysis International. 34 (4): 353–7. June 2014. doi:10.3747/pdi.2013.00344. PMC 4079480. PMID 24711640.
"Molecular mechanism of action of metformin: old or new insights?". Diabetologia. 56 (9): 1898–906. September 2013. doi:10.1007/s00125-013-2991-0. PMC 3737434. PMID 23835523.
"The antidiabetic gutsy role of metformin uncovered?". Gut. 63 (5): 706–7. May 2014. doi:10.1136/gutjnl-2013-305370. PMID 23840042.
"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase". Nature. 510 (7506): 542–6. June 2014. Bibcode:2014Natur.510..542M. doi:10.1038/nature13270. PMC 4074244. PMID 24847880. Unknown parameter |displayauthors= ignored (bantuan)
"The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials". Pharmacological Research. 159: 104799. September 2020. doi:10.1016/j.phrs.2020.104799. PMID 32278041. Unknown parameter |displayauthors= ignored (bantuan)
"Diabetes drugs for nonalcoholic fatty liver disease: a systematic review". Systematic Reviews. 8 (1): 295. November 2019. doi:10.1186/s13643-019-1200-8. PMC 6884753. PMID 31783920.
"Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis". World Journal of Gastroenterology. 24 (30): 3361–3373. August 2018. doi:10.3748/wjg.v24.i30.3361. PMC 6092580. PMID 30122876.
"Metformin treatment to prevent early puberty in girls with precocious pubarche". The Journal of Clinical Endocrinology and Metabolism. 91 (8): 2888–91. August 2006. doi:10.1210/jc.2006-0336. PMID 16684823.
"Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence". The Journal of Clinical Endocrinology and Metabolism. 96 (8): E1262-7. August 2011. doi:10.1210/jc.2011-0555. PMID 21632811.
"Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism". Reviews in Endocrine & Metabolic Disorders. 10 (1): 63–76. March 2009. doi:10.1007/s11154-008-9096-y. PMID 18726694.
"Effect of metformin on prostate cancer outcomes after radical prostatectomy". Urologic Oncology. 32 (1): 43.e1–7. Januari 2014. doi:10.1016/j.urolonc.2013.05.005. PMC 4006350. PMID 23810664. Metformin use at time of RP was extracted from the Mayo Clinic electronic medical record (EMR) by searching in the 3 months prior to the RP for the terms- metformin, Glucophage, Glumetza, Riomet, Fortamet, Obimet, Gluformin, Dianben, Diabex, Diaformin or Metsol.
"Metformin in cancer therapy: a new perspective for an old antidiabetic drug?". Molecular Cancer Therapeutics. 9 (5): 1092–9. May 2010. doi:10.1158/1535-7163.MCT-09-1186. PMID 20442309.
"Risk of cancer in diabetes: the effect of metformin". ISRN Endocrinology. 2013: 636927. September 2013. doi:10.1155/2013/636927. PMC 3800579. PMID 24224094.
"Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis". Ageing Research Reviews. 40: 31–44. November 2017. doi:10.1016/j.arr.2017.08.003. PMID 28802803.
"Metformin as Anti-Aging Therapy: Is It for Everyone?". Trends in Endocrinology and Metabolism. 30 (10): 745–755. October 2019. doi:10.1016/j.tem.2019.07.015. PMC 6779524. PMID 31405774.
"Metformin: A Hopeful Promise in Aging Research". Cold Spring Harbor Perspectives in Medicine. 6 (3): a025932. March 2016. doi:10.1101/cshperspect.a025932. PMC 4772077. PMID 26931809.
"Metformin for Treatment of Fragile X Syndrome and Other Neurological Disorders". Annual Review of Medicine. 70: 167–181. Januari 2019. doi:10.1146/annurev-med-081117-041238. PMID 30365357. Diarkibkan daripada yang asal pada 6 Mac 2023. Dicapai pada 9 Oktober 2022.
"Repurposing metformin: an old drug with new tricks in its binding pockets". The Biochemical Journal. 471 (3): 307–22. November 2015. doi:10.1042/bj20150497. PMC 4613459. PMID 26475449.
"Metformin as a Tool to Target Aging". Cell Metabolism. 23 (6): 1060–1065. June 2016. doi:10.1016/j.cmet.2016.05.011. PMC 5943638. PMID 27304507.
"A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan". Frontiers in Endocrinology. 12: 718942. 2021. doi:10.3389/fendo.2021.718942. PMC 8374068 Check |pmc= value (bantuan). PMID 34421827 Check |pmid= value (bantuan).

ncbi.nlm.nih.gov

Lucis OJ (Januari 1983). "The status of metformin in Canada". Canadian Medical Association Journal. 128 (1): 24–6. PMC 1874707. PMID 6847752.
"Metformin in prevention and treatment of antipsychotic-induced weight gain: a systematic review and meta-analysis". BMC Psychiatry. 16 (1): 341. October 2016. doi:10.1186/s12888-016-1049-5. PMC 5048618. PMID 27716110.
"Do Patients Die with or from Metformin-Associated Lactic Acidosis (MALA)? Systematic Review and Meta-analysis of pH and Lactate as Predictors of Mortality in MALA". Journal of Medical Toxicology. 16 (2): 222–229. April 2020. doi:10.1007/s13181-019-00755-6. PMC 7099117. PMID 31907741.
"Use of metformin in the setting of mild-to-moderate renal insufficiency". Diabetes Care. 34 (6): 1431–7. June 2011. doi:10.2337/dc10-2361. PMC 3114336. PMID 21617112.
"GDF15 mediates the effects of metformin on body weight and energy balance". Nature. 578 (7795): 444–448. Februari 2020. doi:10.1038/s41586-019-1911-y. PMC 7234839. PMID 31875646. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis". Proceedings of the National Academy of Sciences of the United States of America. 119 (10): e2122287119. March 2022. Bibcode:2022PNAS..11922287L. doi:10.1073/pnas.2122287119. PMC 8916010 Check |pmc= value (bantuan). PMID 35238637 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Metformin in polycystic ovary syndrome: systematic review and meta-analysis". BMJ. 327 (7421): 951–3. October 2003. doi:10.1136/bmj.327.7421.951. PMC 259161. PMID 14576245.
"Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations". Annals of Internal Medicine. 154 (9): 602–13. May 2011. doi:10.7326/0003-4819-154-9-201105030-00336. PMC 3733115. PMID 21403054. Unknown parameter |displayauthors= ignored (bantuan)
"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)". Diabetes Care. 35 (6): 1364–79. June 2012. doi:10.2337/dc12-0413. PMC 3357214. PMID 22517736. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin monotherapy for adults with type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews. 2020 (6): CD012906. June 2020. doi:10.1002/14651858.CD012906.pub2. PMC 7386876. PMID 32501595.
"Drug interventions for the treatment of obesity in children and adolescents". The Cochrane Database of Systematic Reviews. 11 (11): CD012436. November 2016. doi:10.1002/14651858.CD012436. PMC 6472619. PMID 27899001. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews. 2019 (12): CD008558. December 2019. doi:10.1002/14651858.CD008558.pub2. PMC 6889926. PMID 31794067.
"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility". The Cochrane Database of Systematic Reviews. 11 (2): CD003053. November 2017. doi:10.1002/14651858.CD003053.pub6. PMC 6486196. PMID 29183107. Our updated review suggests that metformin alone Mei be beneficial over placebo for live birth, although the evidence quality was low.
"Effects of metformin use in pregnant patients with polycystic ovary syndrome". Journal of Human Reproductive Sciences. 5 (2): 166–9. May 2012. doi:10.4103/0974-1208.101012. PMC 3493830. PMID 23162354.
"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome". The Cochrane Database of Systematic Reviews. 2020 (12): CD006105. December 2020. doi:10.1002/14651858.CD006105.pub4. PMC 8171384. PMID 33347618.
"Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes". The Cochrane Database of Systematic Reviews. 2018 (7): CD010564. July 2018. doi:10.1002/14651858.CD010564.pub2. PMC 6513233. PMID 30039871.
"Metformin in chronic kidney disease: time for a rethink". Peritoneal Dialysis International. 34 (4): 353–7. June 2014. doi:10.3747/pdi.2013.00344. PMC 4079480. PMID 24711640.
"Molecular mechanism of action of metformin: old or new insights?". Diabetologia. 56 (9): 1898–906. September 2013. doi:10.1007/s00125-013-2991-0. PMC 3737434. PMID 23835523.
"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase". Nature. 510 (7506): 542–6. June 2014. Bibcode:2014Natur.510..542M. doi:10.1038/nature13270. PMC 4074244. PMID 24847880. Unknown parameter |displayauthors= ignored (bantuan)
"Diabetes drugs for nonalcoholic fatty liver disease: a systematic review". Systematic Reviews. 8 (1): 295. November 2019. doi:10.1186/s13643-019-1200-8. PMC 6884753. PMID 31783920.
"Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis". World Journal of Gastroenterology. 24 (30): 3361–3373. August 2018. doi:10.3748/wjg.v24.i30.3361. PMC 6092580. PMID 30122876.
"Effect of metformin on prostate cancer outcomes after radical prostatectomy". Urologic Oncology. 32 (1): 43.e1–7. Januari 2014. doi:10.1016/j.urolonc.2013.05.005. PMC 4006350. PMID 23810664. Metformin use at time of RP was extracted from the Mayo Clinic electronic medical record (EMR) by searching in the 3 months prior to the RP for the terms- metformin, Glucophage, Glumetza, Riomet, Fortamet, Obimet, Gluformin, Dianben, Diabex, Diaformin or Metsol.
"Risk of cancer in diabetes: the effect of metformin". ISRN Endocrinology. 2013: 636927. September 2013. doi:10.1155/2013/636927. PMC 3800579. PMID 24224094.
"Metformin as Anti-Aging Therapy: Is It for Everyone?". Trends in Endocrinology and Metabolism. 30 (10): 745–755. October 2019. doi:10.1016/j.tem.2019.07.015. PMC 6779524. PMID 31405774.
"Metformin: A Hopeful Promise in Aging Research". Cold Spring Harbor Perspectives in Medicine. 6 (3): a025932. March 2016. doi:10.1101/cshperspect.a025932. PMC 4772077. PMID 26931809.
"Repurposing metformin: an old drug with new tricks in its binding pockets". The Biochemical Journal. 471 (3): 307–22. November 2015. doi:10.1042/bj20150497. PMC 4613459. PMID 26475449.
"Metformin as a Tool to Target Aging". Cell Metabolism. 23 (6): 1060–1065. June 2016. doi:10.1016/j.cmet.2016.05.011. PMC 5943638. PMID 27304507.
"A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan". Frontiers in Endocrinology. 12: 718942. 2021. doi:10.3389/fendo.2021.718942. PMC 8374068 Check |pmc= value (bantuan). PMID 34421827 Check |pmid= value (bantuan).

dailymed.nlm.nih.gov

"Glucophage (metformin hydrochloride) tablets, for oral use; Glucophage XR (metformin hydrochloride) extended-release tablets, for oral use Initial U.S. Approval:1995". DailyMed. Diarkibkan daripada yang asal pada 6 Mac 2023. Dicapai pada 5 Mac 2023.
"Glucophage package insert". Princeton, NJ: Bristol-Myers Squibb Company. 2009. Diarkibkan daripada yang asal pada 29 Ogos 2021 – melalui DailyMed.

rcog.org.uk

"Metformin therapy for the management of infertility in women with polycystic ovary syndrome" (PDF). Scientific Advisory Committee Opinion Paper 13. Royal College of Obstetricians and Gynaecologists. December 2008. Diarkibkan daripada yang asal (PDF) pada 18 Disember 2009. Dicapai pada 13 Disember 2009.

semanticscholar.org

api.semanticscholar.org

Sirtori CR, Franceschini G, Galli-Kienle M, Cighetti G, Galli G, Bondioli A, Conti F (Disember 1978). "Disposition of metformin (N,N-dimethylbiguanide) in man". Clinical Pharmacology and Therapeutics. 24 (6): 683–93. doi:10.1002/cpt1978246683. PMID 710026. S2CID 24531910.

tga.gov.au

"Metformin SANDOZ metformin hydrochloride 850mg tablet bottle (148270)". Therapeutic Goods Administration (TGA). 27 Mei 2022. Dicapai pada 29 April 2023.

web.archive.org

"Metformin Use During Pregnancy". Drugs.com. 10 September 2019. Diarkibkan daripada yang asal pada 16 April 2020. Dicapai pada 4 Februari 2020.
"Metformin Hydrochloride". Health Canada. Diarkibkan daripada yang asal pada 6 Mac 2023. Dicapai pada 6 Mac 2023.
"Glucophage 500 mg film coated tablets - Summary of Product Characteristics (SmPC)". (emc). 25 Oktober 2022. Diarkibkan daripada yang asal pada 20 Jun 2022. Dicapai pada 5 Mac 2023.
"Glucophage (metformin hydrochloride) tablets, for oral use; Glucophage XR (metformin hydrochloride) extended-release tablets, for oral use Initial U.S. Approval:1995". DailyMed. Diarkibkan daripada yang asal pada 6 Mac 2023. Dicapai pada 5 Mac 2023.
"Metformin". www.chemsrc.com. Diarkibkan daripada yang asal pada 12 Jun 2017. Dicapai pada 10 Mei 2018.
"Metformin Hydrochloride". The American Society of Health-System Pharmacists. Diarkibkan daripada yang asal pada 24 Disember 2016. Dicapai pada 2 Januari 2017.
Fischer J (2010). Analogue-based Drug Discovery II. John Wiley & Sons. m/s. 49. ISBN 978-3-527-63212-1. Diarkibkan daripada yang asal pada 8 September 2017.
Stargrove MB, Treasure J, McKee DL (2008). Herb, nutrient, and drug interactions : clinical implications and therapeutic strategies. St. Louis, Mo.: Mosby/Elsevier. m/s. 217. ISBN 978-0-323-02964-3. Diarkibkan daripada yang asal pada 8 September 2017.
"The Top 300 of 2020". ClinCalc. Diarkibkan daripada yang asal pada 18 Mac 2020. Dicapai pada 7 Oktober 2022.
"Metformin - Drug Usage Statistics". ClinCalc. Diarkibkan daripada yang asal pada 7 Oktober 2021. Dicapai pada 7 Oktober 2022.
"Glucophage package insert". Princeton, NJ: Bristol-Myers Squibb Company. 2009. Diarkibkan daripada yang asal pada 29 Ogos 2021 – melalui DailyMed.
National Collaborating Centre for Women's and Children's Health (2004). Fertility: assessment and treatment for people with fertility problems (PDF). London: Royal College of Obstetricians and Gynaecologists. m/s. 58–59. ISBN 978-1-900364-97-3. Diarkibkan daripada yang asal (PDF) pada 11 Julai 2009.
"Metformin: medicine to treat type 2 diabetes". National Health Service. 25 Februari 2019. Diarkibkan daripada yang asal pada 11 Mac 2021. Dicapai pada 15 Oktober 2020.
"METFORMIN HYDROCHLORIDE". NICE. Diarkibkan daripada yang asal pada 10 Jun 2021. Dicapai pada 15 Oktober 2020.
"Metformin overdose in dogs and cats" (PDF). Veterinary Medicine (April): 231–33. 2007. Diarkibkan daripada yang asal (PDF) pada 23 Oktober 2007.
"The preparation of methylguanidine, and of ββ-dimethylguanidine by the interaction of dicyandiamide, and methylammonium and dimethylammonium chlorides respectively". J. Chem. Soc., Trans. 121: 1790–95. 1922. doi:10.1039/CT9222101790. Diarkibkan daripada yang asal pada 8 Jun 2021. Dicapai pada 4 September 2020.
"Metformin for Treatment of Fragile X Syndrome and Other Neurological Disorders". Annual Review of Medicine. 70: 167–181. Januari 2019. doi:10.1146/annurev-med-081117-041238. PMID 30365357. Diarkibkan daripada yang asal pada 6 Mac 2023. Dicapai pada 9 Oktober 2022.

webcitation.org

"Metformin therapy for the management of infertility in women with polycystic ovary syndrome" (PDF). Scientific Advisory Committee Opinion Paper 13. Royal College of Obstetricians and Gynaecologists. December 2008. Diarkibkan daripada yang asal (PDF) pada 18 Disember 2009. Dicapai pada 13 Disember 2009.

wikipedia.org

en.wikipedia.org

"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022". Diabetes Care. 45 (Suppl 1): S125–S143. Januari 2022. doi:10.2337/dc22-s009. PMID 34964831 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD". European Heart Journal. 41 (2): 255–323. Januari 2020. doi:10.1093/eurheartj/ehz486. PMID 31497854. Unknown parameter |displayauthors= ignored (bantuan)
"Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis". Annals of Internal Medicine. 164 (11): 740–751. June 2016. doi:10.7326/M15-2650. PMID 27088241. Unknown parameter |displayauthors= ignored (bantuan)
"GDF15 mediates the effects of metformin on body weight and energy balance". Nature. 578 (7795): 444–448. Februari 2020. doi:10.1038/s41586-019-1911-y. PMC 7234839. PMID 31875646. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss". Nature Metabolism. 1 (12): 1202–1208. December 2019. doi:10.1038/s42255-019-0146-4. PMID 32694673. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis". Proceedings of the National Academy of Sciences of the United States of America. 119 (10): e2122287119. March 2022. Bibcode:2022PNAS..11922287L. doi:10.1073/pnas.2122287119. PMC 8916010 Check |pmc= value (bantuan). PMID 35238637 Check |pmid= value (bantuan). Unknown parameter |displayauthors= ignored (bantuan)
"Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations". Annals of Internal Medicine. 154 (9): 602–13. May 2011. doi:10.7326/0003-4819-154-9-201105030-00336. PMC 3733115. PMID 21403054. Unknown parameter |displayauthors= ignored (bantuan)
"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)". Diabetes Care. 35 (6): 1364–79. June 2012. doi:10.2337/dc12-0413. PMC 3357214. PMID 22517736. Unknown parameter |displayauthors= ignored (bantuan)
"ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary". Diabetes & Vascular Disease Research. 11 (3): 133–73. May 2014. doi:10.1177/1479164114525548. PMID 24800783. Unknown parameter |displayauthors= ignored (bantuan)
"Drug interventions for the treatment of obesity in children and adolescents". The Cochrane Database of Systematic Reviews. 11 (11): CD012436. November 2016. doi:10.1002/14651858.CD012436. PMC 6472619. PMID 27899001. Unknown parameter |displayauthors= ignored (bantuan)
"Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus". Annals of Internal Medicine. 147 (6): 386–99. September 2007. doi:10.7326/0003-4819-147-6-200709180-00178. PMID 17638715. Unknown parameter |displayauthors= ignored (bantuan)
"Pharmacological and surgical treatment of nonreproductive outcomes in polycystic ovary syndrome: An overview of systematic reviews". Clinical Endocrinology. 89 (5): 535–553. November 2018. doi:10.1111/cen.13753. PMID 29846959. Unknown parameter |displayauthors= ignored (bantuan)
"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase". Nature. 510 (7506): 542–6. June 2014. Bibcode:2014Natur.510..542M. doi:10.1038/nature13270. PMC 4074244. PMID 24847880. Unknown parameter |displayauthors= ignored (bantuan)
"The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials". Pharmacological Research. 159: 104799. September 2020. doi:10.1016/j.phrs.2020.104799. PMID 32278041. Unknown parameter |displayauthors= ignored (bantuan)
"A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan". Frontiers in Endocrinology. 12: 718942. 2021. doi:10.3389/fendo.2021.718942. PMC 8374068 Check |pmc= value (bantuan). PMID 34421827 Check |pmid= value (bantuan).

zenodo.org

"The preparation of methylguanidine, and of ββ-dimethylguanidine by the interaction of dicyandiamide, and methylammonium and dimethylammonium chlorides respectively". J. Chem. Soc., Trans. 121: 1790–95. 1922. doi:10.1039/CT9222101790. Diarkibkan daripada yang asal pada 8 Jun 2021. Dicapai pada 4 September 2020.